Researchers at the University of Louisville have discovered that synthetic cooling agents used in e-cigarettes can severely disrupt cardiac electrical activity. Published in the American Heart Association's journal, Circulation: Arrhythmia and Electrophysiology, the study raises critical safety concerns regarding non-nicotine additives designed to make vaping more palatable.
To mask the harshness of nicotine and make inhalation smoother, manufacturers heavily rely on cooling agents. While natural menthol is a well-known additive, synthetic alternatives like WS-3 and WS-23 have surged in popularity. According to lead investigator Alex Carll, these chemicals are frequently added to e-cigarettes at exceptionally high concentrations, often surpassing the levels of nicotine itself.
The research team tested the cardiovascular impact of these cooling agents using animal models and cultivated human cardiac cells. When exposed to e-cigarette aerosols containing WS-23, the animal subjects experienced immediate neurological and cardiac disruptions.
The study identified several cardiovascular anomalies during exposure:
- Heart Rate Fluctuations: Significant and sudden alterations in normal heart rates.
- Premature Beats: An increase in extrasystoles (premature heartbeats) compared to exposure to nicotine alone.
- Disrupted Cardiac Cycles: Abnormalities in the timing between the heart's contraction and relaxation phases.
In the second phase of the study, researchers exposed cultivated human cardiac cells to the same cooling compounds. Interestingly, the electrical anomalies in human cells became most prominent when the exposure was paired with norepinephrine—the hormone responsible for the body's fight-or-flight response. This suggests that vaping these cooling agents during periods of physical or emotional stress could amplify the risk of acute cardiac events.
While further clinical trials on human subjects are required to fully map these long-term effects, the study highlights a critical gap in vapor product safety. Beyond nicotine addiction, chronic vaping is already associated with severe health risks, including:
- Chronic Pulmonary Diseases: Conditions such as chronic bronchitis, emphysema, and pulmonary fibrosis.
- Cardiovascular Damage: Increased blood pressure, arterial stiffness, and elevated risk of stroke or myocardial infarction.
- EVALI: Acute, life-threatening lung injury caused by toxic chemical inhalation.
The researchers conclude that regulatory bodies must evaluate and potentially restrict the permissible levels of synthetic cooling agents in commercial e-cigarettes to safeguard public health from hidden cardiovascular threats.
Vape Lifestyle & Advocacy Blogger
Chloe Evans, widely known as "CloudChaser Chloe," is a prominent voice in the global vaping community, celebrated for her vibrant personality and keen focus on the lifestyle aspects of vaping. Based in the creative hub of Portland, Oregon, Chloe's content blends fashion, art, and harm reduction, offering a fresh perspective on the vaping world. She aims to demystify vaping for adult consumers and challenge outdated perceptions, promoting a responsible and enjoyable experience.